UK-based pharma major GlaxoSmithKline will invest Rs 1,000 crore to set up a new greenfield pharmaceuticals manufacturing unit in Karnataka.
UK-based pharma major GlaxoSmithKline will invest Rs 1,000 crore to set up a new greenfield pharmaceuticals manufacturing unit in Karnataka. The state has sanctioned 50 acres at Vemgal Industrial Area in Kolar district for setting up the new plant, where the company will manufacture tablets and capsules.
According to a statement issued by K Ratna Prabha, additional chief secretary to the government of Karnataka, the company will generate 232 jobs at this facility. This will be GSK’s first facility coming up in the last 15 years anywhere in the world, the statement added.
GlaxoSmithKline Pharmaceuticals is one of the oldest pharmaceuticals companies established in the year 1924 in India, employing over 4,500 people. GSK has two manufacturing units in India, at Nashik and Thane, as well as a clinical development centre in Bengaluru.
Ian Felton, deputy high commissioner, British Deputy High Commission, Bengaluru, along with Richard Heald, CEO, UK India Business Council, on Tuesday held discussions with the state government on GSK’s expansion plans in Bengaluru.